UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications

Biochemical Society transactions, 2014-04, Vol.42 (2), p.450

Beisswenger, Paul J

2014

Volltextzugriff (PDF)

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study

Diabetes care, 2017-04, Vol.40 (4), p.591-598

2017

Volltextzugriff (PDF)

Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans

Nutrients, 2019-03, Vol.11 (3), p.532

2019

Volltextzugriff (PDF)

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Diabetes care, 2022-03, Vol.45 (3), p.684-691

2022

Volltextzugriff (PDF)

Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM

Nutrients, 2019-02, Vol.11 (2), p.386

2019

Volltextzugriff (PDF)

Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts

Journal of the American Heart Association, 2022-08, Vol.11 (15), p.e024012-e024012

2022

Volltextzugriff (PDF)

Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress

Diabetes (New York, N.Y.), 2005-11, Vol.54 (11), p.3274-3281

2005

Volltextzugriff (PDF)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

Diabetes care, 2018-03, Vol.41 (3), p.570-576

2018

Volltextzugriff (PDF)

Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes

Diabetes care, 2005-10, Vol.28 (10), p.2465-2471

2005

Volltextzugriff (PDF)

Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study

Journal of diabetes research, 2023, Vol.2023, p.1-10

2023

Volltextzugriff (PDF)

Ketosis Leads to Increased Methylglyoxal Production on the Atkins Diet

Annals of the New York Academy of Sciences, 2005-06, Vol.1043 (1), p.201-210

2005

Volltextzugriff (PDF)

187-OR: Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in the ACCORD Trial

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691

Diabetes care, 2022-06, Vol.45 (6), p.e111-e112

2022

Volltextzugriff (PDF)

Glycation and biomarkers of vascular complications of diabetes

Amino acids, 2012-04, Vol.42 (4), p.1171-1183

Beisswenger, Paul J.

2012

Volltextzugriff (PDF)

Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products

Diabetes care, 2013-10, Vol.36 (10), p.3234-3239

2013

Volltextzugriff (PDF)

Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction

Basic research in cardiology, 2017-09, Vol.112 (5), p.57-57, Article 57

2017

Volltextzugriff (PDF)

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes

Diabetes (New York, N.Y.), 2016-12, Vol.65 (12), p.3744-3753

2016

Volltextzugriff (PDF)

α-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia

Diabetes care, 2001-04, Vol.24 (4), p.726-732

2001

Volltextzugriff (PDF)

Advanced Glycation End Products (AGEs)-Role in Development and Progression of Kidney Disease in Type 1 Diabetes in DCCT/EDIC

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison

Clinical therapeutics, 2007-11, Vol.29 (11), p.2349-2364

2007

Volltextzugriff (PDF)

Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV

Journal of acquired immune deficiency syndromes (1999), 2019-06, Vol.81 (2), p.e55

2019

Volltextzugriff (PDF)

Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal

Journal of renal nutrition, 2023-01, Vol.33 (1), p.181-192

2023

Volltextzugriff (PDF)

Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation

Amino acids, 2014-02, Vol.46 (2), p.311-319

2014

Volltextzugriff (PDF)

Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes

Diabetes technology & therapeutics, 2012-03, Vol.14 (3), p.285

2012

Volltextzugriff (PDF)

198-LB: Maternal Plasma AGEs and Preeclampsia in Women with Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(59)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(40)
Diabetes
(24)
Middle Aged
(22)
Endocrinology & Metabolism
(20)
Male
(19)
Adult
(17)
Female
(17)
Biological And Medical Sciences
(12)
Glycation End Products, Advanced - Metabolism
(12)
Medical Sciences
(12)
Biochemistry & Molecular Biology
(11)
Glycosylation
(11)
Diabetes. Impaired Glucose Tolerance
(10)
Endocrine Pancreas. Apud Cells
(10)
Endocrinopathies
(10)
Advanced Glycosylation End Products
(9)
Age
(9)
Diabetes Mellitus, Type 2 - Blood
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study

Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes

Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM

Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts

Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes

Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study

Ketosis Leads to Increased Methylglyoxal Production on the Atkins Diet

187-OR: Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes in the ACCORD Trial

Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684-691

Glycation and biomarkers of vascular complications of diabetes

Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products

Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes

α-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia

Advanced Glycation End Products (AGEs)-Role in Development and Progression of Kidney Disease in Type 1 Diabetes in DCCT/EDIC

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison

Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV

Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal

Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation

Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes

198-LB: Maternal Plasma AGEs and Preeclampsia in Women with Type 1 Diabetes

Suchergebnisse filtern